輸入代號或公司名稱後按 Enter
1733

五鼎

+0.35 (+1.17%)最後更新 2026-09-16
台灣 · 上市 · 生技醫療業
30.2583成交張數15.74本益比1.61股價淨值比4.35%殖利率2026-09-16資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入20251,945年增 +5.0%
毛利率202527.7%最新一期
營業利益率20257.2%最新一期
每股盈餘20251.63年增 +27.3%
會計項目走勢20212022202320242025
營業收入合計100.0%100.0%100.0%100.0%100.0%
營業成本合計73.2%74.3%68.3%71.9%72.3%
營業毛利(毛損)26.8%25.7%31.7%28.1%27.7%
營業毛利(毛損)淨額26.8%25.7%31.7%28.1%27.7%
推銷費用5.0%5.2%6.2%5.7%5.3%
管理費用5.2%5.3%7.2%6.7%6.7%
研究發展費用7.2%7.4%9.7%8.7%7.7%
預期信用減損損失(利益)-0.2%0.0%0.1%0.0%0.7%
營業費用合計17.2%17.8%23.2%21.2%20.5%
營業利益(損失)9.6%7.9%8.5%6.9%7.2%
利息收入0.0%0.0%0.1%0.1%0.2%
其他收入0.8%0.1%0.3%0.2%0.4%
其他利益及損失淨額-1.2%1.1%-0.2%1.2%2.2%
財務成本淨額0.6%0.2%0.3%0.2%0.2%
營業外收入及支出合計-0.9%1.0%-0.0%1.3%2.5%
稅前淨利(淨損)8.7%8.9%8.4%8.3%9.8%
所得稅費用(利益)合計-0.8%0.8%1.5%1.4%1.4%
繼續營業單位本期淨利(淨損)9.5%8.1%6.9%6.9%8.4%
本期淨利(淨損)9.5%8.1%6.9%6.9%8.4%
確定福利計畫之再衡量數0.1%0.3%0.2%0.4%0.2%
不重分類至損益之項目:0.1%0.3%0.2%0.4%0.2%
國外營運機構財務報表換算之兌換差額-0.1%0.3%0.0%0.1%-0.1%
後續可能重分類至損益之項目:-0.1%0.3%0.0%0.1%-0.1%
其他綜合損益(淨額)0.0%0.6%0.2%0.5%0.2%
本期綜合損益總額9.5%8.7%7.1%7.4%8.5%
母公司業主(淨利∕損)9.5%8.1%6.9%6.9%8.4%
非控制權益(淨利∕損)0.0%-0.0%-0.0%0.0%0.0%
母公司業主(綜合損益)9.5%8.7%7.1%7.4%8.5%
非控制權益(綜合損益)0.0%-0.0%-0.0%0.0%0.0%
基本每股盈餘0.1%0.1%0.1%0.1%0.1%
稀釋每股盈餘0.1%0.1%0.1%0.1%0.1%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。